483
Bausch Health US., LLC.Bausch Health US., LLC. – FDA 483, Nov 7, 2024
Record Details
During an inspection, Bausch Health US., LLC. was cited for failing to maintain adequate drug distribution and dispensing records for its approved REMS Implementation System. Specifically, the firm did not ensure that SILIQ was only distributed to certified pharmacies, as required by its REMS program. This indicates a significant lapse in oversight regarding restricted drug distribution.
View Company Profile
ID · 3e4f42e1-1b96-426a-8138-68ddf864f234
Other documents for Bausch Health US., LLC.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.